Relay Therapeutics, Inc. planned insider sales
In the last twelve months insiders at Relay Therapeutics, Inc. filed 15 Form 144 notices of planned sales, 7.0 million shares worth $141.2 million at the time of filing, from 7 sellers. The latest, filed 7 October 2026: Sanjiv Patel (director, officer), 96,401 shares worth $1.8 million, planned for around 7 October 2026 through Morgan Stanley Smith Barney LLC Executive Financial Services.
| Filed | Seller | Relationship | Shares | Value | Planned sale | Sold, per Form 4 | Broker | How acquired | Filing |
|---|---|---|---|---|---|---|---|---|---|
| 7 October 2026 | Sanjiv Patel | Director, Officer | 96,401 | $1.8 million | 7 October 2026 | 48,199 shares from 7 October 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 6 October 2026 | Thomas Catinazzo | Officer | 93,153 | $1.8 million | 6 October 2026 | 17,717 shares from 6 October 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted and Performance Stock Units | Form 144 |
| 26 August 2026 | Peter Rahmer | Officer | 50,000 | $1.0 million | 26 August 2026 | 4,508 shares from 26 August 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 25 August 2026 | SVF Pauling (Cayman) Ltd | Stockholder | 6,000,000 | $123.4 million | 25 August 2026 | 6,000,000 shares from 25 August 2026 | Citigroup Global Markets Inc. | Acquired upon the automatic conversion of Series C Convertible Preferred Stock upon the closing of the Issuer's initial public offering. The shares were acquired and fully paid for in December 2018. | Form 144 |
| 4 August 2026 | Sekar Kathiresan | Director | 42,225 | $826,466 | 4 August 2026 | None on Form 4 yet | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 31 July 2026 | Sekar Kathiresan | Director | 30,000 | $563,553 | 31 July 2026 | None on Form 4 yet | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 21 July 2026 | Sekar Kathiresan | Director | 30,000 | $594,414 | 21 July 2026 | No matching Form 4 sale | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 20 July 2026 | Sekar Kathiresan | Director | 66,055 | $1.3 million | 20 July 2026 | No matching Form 4 sale | Morgan Stanley Smith Barney LLC Executive Financial Services | Stock Option Exercise | Form 144 |
| 7 July 2026 | Sanjiv Patel | Director, Officer | 144,597 | $2.7 million | 7 July 2026 | 144,597 shares from 7 July 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 30 June 2026 | Peter Rahmer | Officer | 50,000 | $987,000 | 30 June 2026 | 50,748 shares from 30 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Performance Stock Units | Form 144 |
| 22 June 2026 | Donald Bergstrom | Officer | 110,646 | $1.8 million | 22 June 2026 | 112,883 shares from 22 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options; Restricted Stock Units | Form 144 |
| 22 June 2026 | Thomas Catinazzo | Officer | 204,880 | $3.3 million | 22 June 2026 | 241,773 shares from 22 June 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Exercise of Stock Options; Performance Stock Units; Restricted Stock Units | Form 144 |
| 14 May 2026 | Thomas Catinazzo | Officer | 37,234 | $492,233 | 14 May 2026 | 17,717 shares from 14 May 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted and Performance Stock Units | Form 144 |
| 9 March 2026 | Thomas Catinazzo | Officer | 53,151 | $525,663 | 9 March 2026 | 38,206 shares from 9 March 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock Units | Form 144 |
| 29 October 2025 | Peter J Rahmer | Officer | 21,394 | $160,436 | 29 October 2025 | 52,213 shares from 28 October 2025 | Morgan Stanley Smith Barney LLC Executive Financial Services | Restricted Stock | Form 144 |
A Form 144 is the notice an insider files with the SEC before selling restricted or control shares over the Rule 144 thresholds; it says what may be sold, not what was.